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Abstract
Background : To investigate the relationship of the neck circumference (NC) with non-alcoholic fatty liver disease
(NAFLD) in non-obese Chinese population.
Methods: Our data were obtained from a cross-sectional survey on the prevalence of metabolic diseases and risk
factors in East China in 2014. Subjects with a BMI ≥ 18.5 kg/m2 and < 25 kg/m2 were considered normal weight. A
total of 2668 participants aged 18–89 were identified for analysis. Anthropometric indices, biochemical parameters,
clinical characteristics and abdominal ultrasound were measured. Independent predictors of NAFLD were identified
by multiple logistic regressions.
Results: The overall prevalence of NAFLD was 10.94 % in this study population and men had a higher prevalence
than women (19.89 % vs 7.48 %, P < 0.01). The mean NC was greater in NAFLD subjects compared with other
groups in both genders (P < 0.01). NC was correlated to BMI, waist circumference, hip circumference, systolic blood
pressure, diastolic blood pressure, insulin, HOMA-IR, triglycerides and ALT, regardless of sex. In the highest quartile
of NC levels in men but not in women, the risks were substantially higher for NAFLD [odds ratio 2.18, (95 %
confidence interval 1.16–4.13)] (P < 0.001 for trend) after adjusting for potential confounding factors.
Conclusion: NC was an independent indicator for NAFLD in normal weighted men.
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Background
The distribution of body fat is an important factor that
determines metabolic health [1]. Many researchers have
shown that upper-body subcutaneous adipose tissue may
confer additional risk for metabolic disorders beyond
overall and central adiposity [2, 3]. The neck circumfer-
ence (NC) measurement is a surrogate marker of deter-
mining upper-body subcutaneous distribution and the
close correlations between NC and various metabolic
risk factors have been widely explored [3–5].
Non-alcoholic fatty liver disease (NAFLD) has a close
relationship with components of metabolic syndrome
and is considered the hepatic manifestation of metabolic
syndrome [6]. Although NAFLD is the most common
cause of abnormal liver function tests owing to the rapid
rise in the prevalence of obesity, now the high preva-
lence of NAFLD in normal weight people has drawn
great attention[7]. NAFLD is usually considered an inci-
dental pathologic finding, with scarce or no clinical
symptoms. Hence, identifying NAFLD in those with a
normal weight might have important clinical signifi-
cance. Early diagnosis and management would also ef-
fectively improve its prognosis [8, 9].
From a clinical perspective, NAFLD is characterized
by ectopic fat deposition [10]. NC is an alternative meas-
urement for upper-body subcutaneous fat and is also a
good indicator of ectopic fat distribution [4, 11]. There-
fore, NC measurement may play a vital role in NAFLD
clinical prediction. Although NC now has been proposed
as an effective predictor for NAFLD in the general
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population [8], no detailed data is available to describe
the relationship between the NC and NAFLD in normal
weight people. Here we conduct this study to obtain a
better understanding of the associations between NC
and NAFLD and other metabolic risk factors.
Methods
Subjects
A cross-sectional survey to evaluate the prevalence of
metabolic diseases and risk factors in East China was
performed in 2014 (SPECT-China, ChiCTRECS-
14005052, www.chictr.org). The details of the study de-
sign have been described previously [12]. In brief, the
study was conducted from February to June 2014. Six
residential areas in Shanghai, seven in Jiangxi province
and three in Zhejiang province were selected using a
stratified and cluster sampling method. Using included
and excluded criteria as presented before, a total of 7200
Chinese residents participated in this investigation. After
exclusion of participants who had complete missing la-
boratory results (n = 183), missing questionnaire data (n
= 112) and were younger than 18-year-old (n = 6), 6899
subjects were enrolled in SPECT-China study finally
[12]. The study design and procedures were approved by
the Ethics Committee of Shanghai Jiaotong University
Affiliated Ninth People’s Hospital, and written informed
consents were obtained from all participants.
Normal weight was defined as BMI ≥ 18.5 kg/m2 and
BMI < 25 kg/m2. Candidates were excluded according to
the following additional criteria: previous/current exces-
sive alcohol intake (male > 20 g/d, female > 10 g/d),
hepatitis, long-term use of estrogens, goiter or other
neck masses or deformity with ultrasound. Finally, 2668
individuals aged 18–89 years were analyzed. The partici-
pants’ inclusion and exclusion in this analysis were show
in Fig. 1.
Anthropometric and laboratory evaluation
Data collection was conducted by trained staff according
to a standard protocol. A questionnaire including infor-
mation on demographic characteristics, medical history,
and lifestyle factors was administered by trained inter-
viewers [13]. Anthropometric measurements were taken
to obtain height and weight according to standard tech-
nique by trained investigators. Participants stood on the
weight scale (body-weight balance attached with height
gauge) with bare feet close together, arms at the side and
wore little clothing [14]. Body mass index (BMI) was
calculated as the weight in kilograms divided by the
square of the height in meters. Waist circumference
(WC) was measured on the midaxillary line between the
lower border of the rib cage and the upper margin of
the iliac crest. NC was measured with head erect and
eyes facing forward, horizontally at the upper margin of
the laryngeal prominence with a flexible tape [2]. Insulin
resistance was estimated by the homeostatic model as-
sessment (HOMA-IR) index: [fasting insulin (mIU/L)]
*[FPG (mmol/L)]/22.5. Modification of diet in renal dis-
ease (MDRD) equation recalibrated for Chinese was
used to estimate eGFR expressed in ml/min/ 1.73 m2:
eGFR = 186 * [SCR *0.011]1.154 *[age]0.203 * [0.742 if fe-
male] *1.233, where SCR is serum creatinine expressed
as mmol/l and 1.233 is the coefficient for Chinese [15].
Peripheral venous blood samples were collected after
an overnight fast of at least 8 h. All samples were centri-
fuged immediately after collection and then shipped by
air in dry ice to a central laboratory within 2–4 h of col-
lection. Glycated hemoglobin (HbA1c) was assessed by
high-performance liquid chromatography (MQ-2000PT,
China). Plasma glucose, alanine aminotransferase (ALT),
aspartate aminotransferase (AST) and lipid profile in-
cluding total cholesterol (TC), triglycerides (TG), high
density lipoprotein-cholesterol (HDL-c) and low density
lipoprotein-cholesterol (LDL-c) were measured by
BECKMAN COULTER AU 680 (Germany). Insulin was
detected by chemiluminescence method (Abbott i2000
SR, USA).
NAFLD evaluation
Guidelines for the diagnosis of NAFLD proposed by the
Asia–Pacific Working Party were used [15, 16]. NAFLD was
clinically defined as manifestations of B ultrasonography,
Fig. 1 Flowchart of participants’ inclusion and exclusion
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ruling out the habit of drinking and the history of specific
diseases that could result in fatty liver [15]. Abdominal ultra-
sonography was performed by experienced radiologists who
were blinded to clinical presentation and laboratory findings
[15]. Hepatic steatosis was defined as a diffuse increase of
fine echoes in the liver parenchyma compared with that in
the kidney or spleen parenchyma based on standard criteria
[15].
Statistical analysis
Data management and statistical analyses were per-
formed using IBM SPSS Statistics, Version 22 (IBM Cor-
poration, Armonk, NY, USA). Normally distributed data
were expressed as mean ± SD, whereas variables with a
non-normally distribution were reported as median with
interquartile range and were logarithmically transformed
before analysis. Comparisons between groups were
tested by Student’s t-test and analysis of variance
(ANOVA), in case of normally distributed variables; and
Mann–Whitney U and Kruskal-Wallis test for skewed
distributed variables. The composition of rate was calcu-
lated by Chi-square tests. Spearman’s correlation
coefficient was employed to test the correlations be-
tween different variables. To identify independent risk
factors of NAFLD, multiple logistic regressions models
were used and variables that were biologically likely to
be related with NAFLD were analyzed. Odds ratio (OR)
per standard deviation was used to show the relative




Of the 2668 subjects evaluated, mean age was 50.07 ±
14.09 years with a slight female preponderance (F: M =
2.6:1), for men were more likely to be obesity. Overall,
the prevalence of NAFLD was 10.94 % in this study
population, and was 19.89 % in men and 7.48 % in
women. Clinical characteristics of the participants were
presented in Table 1, separately according to the severity
of liver fat infiltration. In men, age changed minimally
with NAFLD status. While in women, mean age levels
gradually increased from normal people to NAFLD sub-
jects (P < 0.001), which was in agreement with previous
Table 1 General characteristics of participants categorized severity of liver fat infiltration
Men Women
Normal Mild Moderate to severe P Normal Mild Moderate to severe P
N 435 161 148 1470 310 144
Age (yr) 52.03 ± 15.06 47.81 ± 15.88 49.16 ± 15.56 0.06 48.24 ± 13.80 54.55 ± 12.24 56.58 ± 10.71 <0.01
Weight (kg) 61.15 ± 6.42 65.03 ± 6.52 66.29 ± 6.69 <0.01 54.10 ± 5.42 55.95 ± 5.44 57.44 ± 4.45 <0.01
Neck circumference (cm) 34.08 ± 2.16 34.78 ± 2.04 35.45 ± 2.10 <0.01 30.92 ± 2.25 31.33 ± 1.96 31.99 ± 2.09 <0.01
Waist circumference (cm) 76.17 ± 6.60 78.43 ± 6.70 80.08 ± 6.27 <0.01 71.09 ± 6.85 75.08 ± 6.05 78.18 ± 6.68 <0.01
Hip circumference (cm) 89.56 ± 4.66 91.77 ± 5.60 92.16 ± 5.03 0.87 89.56 ± 4.73 90.39 ± 5.18 91.14 ± 4.92 <0.01
Waist to hip ratio 0.87 ± 0.07 0.86 ± 0.07 0.87 ± 0.47 0.04 0.80 ± 0.07 0.83 ± 0.07 0.86 ± 0.47 <0.01
BMI (kg/m2) 21.98 ± 1.69 22.46 ± 1.70 23.13 ± 1.46 <0.01 21.90 ± 1.69 22.84 ± 1.46 23.48 ± 1.27 <0.01
SBP (mmHg) 125.74 ± 19.27 127.64 ± 17.90 129.88 ± 17.83 0.06 121.98 ± 20.11 128.71 ± 19.59 133.57 ± 21.48 <0.01
DBP (mmHg) 76.69 ± 11.64 77.24 ± 12.90 78.23 ± 12.05 0.41 72.75 ± 11.69 77.01 ± 11.90 79.56 ± 12.75 <0.01
FBG (mmol/L) 5.42 ± 1.36 5.29 ± 0.99 5.53 ± 1.41 0.28 5.35 ± 0.93 5.62 ± 1.13 6.02 ± 1.51 <0.01
Fasting insulin (pmol/L) 25.6(17.8–33.3) 27.4(20.0–38.6) 31.6(22.2–46.4) <0.01 30.1(22.6–40.6) 33.8(24.7–46.1) 40.9(29.6–56.5) <0.01
HbA1c (%) 5.28 ± 0.88 5.24 ± 0.70 5.43 ± 1.10 0.14 5.12 ± 0.60 5.30 ± 0.73 5.48 ± 0.89 <0.01
HOMA-IR 0.85(0.57–1.17) 0.90(0.63–1.30) 1.06(0.73–1.65) <0.01 1.03(0.73–1.39) 1.17(0.85–1.65) 1.57(1.12–2.16) <0.01
Total cholerterol (mmol/L) 4.84 ± 0.92 4.70 ± 0.89 4.89 ± 1.17 0.21 4.89 ± 0.93 5.15 ± 1.09 5.26 ± 0.89 <0.01
LDL-cholesterol (mmol/L) 2.76 ± 0.66 2.82 ± 0.61 2.97 ± 0.70 <0.01 2.77 ± 0.69 2.94 ± 0.75 3.08 ± 0.62 <0.01
HDL-cholesterol (mmol/L) 1.40 ± 0.28 1.32 ± 0.27 1.28 ± 0.27 <0.01 1.57 ± 0.30 1.50 ± 0.31 1.40 ± 0.28 <0.01
Triglycerides (mmol/L) 1.10(0.87–1.48) 1.24(0.91–1.76) 1.50(1.02–2.05) <0.01 1.03(0.77–1.38) 1.32(0.95–1.77) 1.77(1.34–2.45) <0.01
Creatinine (umol/L) 87.01 ± 14.31 88.23 ± 12.04 90.39 ± 13.16 0.03 68.75 ± 11.39 68.61 ± 11.15 69.80 ± 10.33 0.53
eGFR (ml/min/1.732) 91.58 ± 17.58 91.03 ± 14.85 87.82 ± 13.14 0.05 90.29 ± 16.63 88.22 ± 17.42 85.04 ± 14.05 <0.01
ALT(U/L) 19(15–25) 18(14–25.5) 22(16–32) 0.04 14(11–19) 16(13–21) 20(15–28.5) <0.01
AST (U/L) 24(20–28) 22(19–27) 23(20–30) <0.01 21(18–25) 22(19–26) 24(20.5–28) <0.01
Smoker N, (%) 140(32.18 %) 53(32.92 %) 52(35.14 %) 0.04 20(1.36 %) 2(0.65 %) 3(2.1 %) 0.12
SBP: systolic blood pressure; DBP: diastolic blood pressure; FBG: fasting blood glucose
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studies both in normal weighted people and in the gen-
eral population. NC, along with other anthropometric
measures such as body weight, WC, hip circumference
(HC) and BMI, tended to be higher with greater NAFLD
severity in both genders. The blood pressure, fasting
blood glucose, fasting insulin, HbA1c, HOMA-IR, TC,
TG, and LDL-c, as well as ALT, AST, showed a graded
increase with increasing severity of NAFLD in women
(P < 0.01). But in males, such tendencies were only ob-
served in fasting insulin, HOMA-IR, TG and LDL-c (P
< 0.05). The mean HDL-c and eGFR of the participants
were the lowest in the NAFLD group, followed by mild
group and normal group in both genders (all P < 0.001).
The characteristics of the study participants according
to quartile of NC are presented in Table 2 and Table 3.
The mean value of NC was 32.02 ± 2.68 cm in the total
participants, and men had a NC 3.5 cm wider than
women (34.50 ± 2.15 vs 31.03 ± 2.22 cm, P < 0.001).
When analyzed by quartiles of NC levels, male individ-
uals with higher NC had more extensive elevations in
BMI, WC and systolic blood pressure, greater levels of
fasting insulin, HOMA-IR and TG (all P < 0.001). The
other potential risk factors analyzed, such as age, dia-
stolic blood pressure, fasting blood glucose, HbA1c, TC
level, LDL-c, HDL-c, ALT, AST and eGFR showed no
graded changes as NC levels increased. At the mean
time, female individuals with higher NC had more ex-
tensive elevations in BMI, WC and blood pressure,
greater levels of fasting blood glucose, fasting insulin,
HbA1c and HOMA-IR, higher levels of TC, TG, LDL-c,
as well as ALT. In contrast, the participants with higher
NC levels displayed lower levels of eGFR and HDL-c in
women (all P < 0.001).
Correlation coefficients for NC
After adjusting for age, partial correlation analysis dem-
onstrated positive correlation between NC and BMI,
WC, HC, systolic blood pressure, diastolic blood pres-
sure, insulin, HOMA-IR, TG and ALT, regardless of sex.
But NC level was negatively correlated with HDL-c
among various metabolic features (Table 4). NC was
positively related to fast blood glucose only in women
while it was positively correlated to TC and LDL -c in
male.
Relationship between NC and NAFLD
Using the binary logistical regression, the independent
and significant clinical parameters associated with
Table 2 Characteristics of study participants according to neck circumference quartiles in men
Men Neck circumference (cm) P
≤33 33–34 34–36 >36
N 229 156 246 113
Age (yr) 52.55 ± 15.39 49.63 ± 15.50 49.39 ± 14.43 50.35 ± 14.14 0.11
weight (kg) 59.39 ± 7.75 62.44 ± 8.08 65.67 ± 8.16 66.18 ± 9.89 <0.01
Waist circumference (cm) 74.81 ± 7.91 76.82 ± 7.32 79.28 ± 7.07 81.46 ± 8.00 <0.01
Hip circumference (cm) 88.72 ± 5.68 89.44 ± 5.10 91.72 ± 5.65 93.78 ± 6.22 <0.01
Waist to hip ratio 0.84 ± 0.08 0.85 ± 0.06 0.90 ± 0.05 0.87 ± 0.07 0.24
BMI (kg/m2) 21.65 ± 2.52 22.16 ± 2.57 22.79 ± 2.50 23.43 ± 2.97 <0.01
SBP (mmHg) 124.05 ± 19.45 126.25 ± 19.17 127.47 ± 17.27 132.59 ± 17.01 <0.01
DBP (mmHg) 76.33 ± 12.67 76.32 ± 11.78 77.03 ± 12.09 78.06 ± 12.41 0.35
FBG (mmol/L) 5.40 ± 1.00 5.31 ± 1.56 5.37 ± 1.21 5.70 ± 1.67 0.08
Fasting insulin (pmol/L) 24.9(16.4–33.1) 27.2(19.2–39.9) 27.7(19.0–35.3) 30.4(21.2–45.8) <0.01
HbA1c (%) 5.26 ± 0.67 5.25 ± 1.09 5.28 ± 0.86 5.47 ± 1.12 0.17
HOMA-IR 0.86(0.57–1.09) 0.88(0.56–1.39) 0.90(0.66–1.22) 1.05(0.72–1.61) <0.01
Total cholerterol (mmol/L) 4.78 ± 0.84 4.80 ± 0.93 4.72 ± 0.82 5.14 ± 1.24 <0.01
LDL-cholesterol (mmol/L) 2.73 ± 0.60 2.80 ± 0.67 2.80 ± 0.59 3.09 ± 0.79 <0.01
HDL-cholesterol (mmol/L) 1.43 ± 0.30 1.36 ± 0.27 1.31 ± 0.25 1.34 ± 0.27 <0.01
Triglycerides (mmol/L) 1.10(0.81–1.37) 1.15(0.89–1.56) 1.25(0.90–1.80) 1.37(0.99–1.93) <0.01
Creatinine (umol/L) 85.63 ± 13.87 88.08 ± 13.74 89.96 ± 15.26 88.86 ± 15.80 <0.01
eGFR (ml/min/1.732) 93.11 ± 16.92 90.45 ± 16.56 89.03 ± 16.08 89.71 ± 16.57 0.04
ALT (U/L) 19(14–25) 21(15–29) 19(15–26) 19(15–29) 0.18
AST (U/L) 24(20–29) 24(20–29) 23(20–28) 22(19–27) 0.35
NAFLD, % 10.04 % 16.67 % 26.02 % 30.97 % <0.01
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NAFLD were identified. The data analysis showed a
strong positive association between HOMA-IR, BMI, TG
and NAFLD, regardless of genders (all P <0.001). Among
male participants, smoke status and NC levels were in-
dependently and significantly associated with NAFLD,
even after adjusting for age, BMI, SBP, WC, TC,
HOMA-IR, ALT and eGFR, the relationships were still
existed. Using NC quartile 1 as a reference, the OR for
NAFLD was 1.47 (95 % CI 0.79–2.75, P < 0.01), 2.07
(95 % CI 1.19–2.75, p <0.01), and 2.18 (95 % CI 1.16–
4.13, P < 0.01) for quartiles 2, 3 and 4 respectively
(Table 5). Additional adjustment for other potential con-
founding factors, ALT and WC were the independent
and significant factors of NAFLD in female subjects.
Discussion
In this cross-sectional analysis of non-obese Chinese
population, prevalence of NAFLD was 10.94 % and the
prevalence in males was obviously higher than in fe-
males (19.89 % vs 7.48 %). These results were compar-
able to previous studies conducted in non-obese
individuals in Japan, Korea and China. The prevalence
reported in these studies was 15.2 %, 12.6 % and 7.2 %
respectively [7, 17, 18]. This may result from a difference
in the study population, because all of those researches
were performed in health checkups while we were com-
munity based cohort study. The gender difference for
the prevalence of NAFLD could be mainly explained by
the female hormones protection against NAFLD and less
smokers in female population.
Furthermore, we showed that ALT, TG, NC levels and
smoke status were independently and significantly asso-
ciated with NAFLD in men. While in women, age, ALT,
TG and HbA1c were independently and significantly as-
sociated with NAFLD. The roles of insulin resistance, al-
terations in lipid metabolism in NAFLD are well
recognized. But here for the first time, we demonstrated
that smoke status was a very important risk factor for
developing NAFLD in non-obese males. While the
mechanism for this association is unclear, several investi-
gators have reported potential pathways. Hongwei et al.
noted that cigarette smoking inactivates 5’- adenosine
monophosphate-activated protein kinase (AMPK) by de-
phosphorylation and promoted triglyceride accumulation
in hepatocytes via activation of sterol regulatory element
binding protein-1 (SREBP-1), inducing fatty liver in mice
fed a high fat diet [19]. In obese rats, cigarette smoking
elevated ALT and caused hepatocellular ballooning and
Table 3 Characteristics of study participants according to neck circumference quartiles in women
Women Neck circumference (cm) P
≤30 30–31 31–32 >32
N 398 463 657 406
Age (yr) 48.17 ± 13.97 49.81 ± 14.13 50.89 ± 13.78 52.14 ± 13.40 <0.01
weight (kg) 50.98 ± 4.66 53.81 ± 4.93 56.10 ± 5.28 56.87 ± 5.44 <0.01
Waist circumference (cm) 67.65 ± 6.20 70.94 ± 5.92 73.56 ± 6.18 76.32 ± 7.42 <0.01
Hip circumference (cm) 86.57 ± 4.48 88.60 ± 4.28 88.67 ± 4.75 91.57 ± 4.75 <0.01
Waist to hip ratio 0.78 ± 0.06 0.80 ± 0.07 0.81 ± 0.07 0.82 ± 0.08 <0.01
BMI (kg/m2) 21.11 ± 1.62 21.96 ± 1.66 22.54 ± 1.53 22.82 ± 1.68 <0.01
SBP (mmHg) 121.27 ± 19.90 121.87 ± 19.38 124.05 ± 20.09 128.69 ± 21.74 <0.01
DBP (mmHg) 72.53 ± 11.22 73.15 ± 11.52 74.24 ± 12.06 75.73 ± 12.75 <0.01
FBG (mmol/L) 5.30 ± 0.78 5.35 ± 1.05 5.46 ± 1.01 5.66 ± 1.26 <0.01
Fasting insulin (pmol/L) 27.5(20.5–37.5) 28.7(21.85–38.15) 33.3(25.0–47.2) 35.9(27.6–46.3) <0.01
HbA1c (%) 5.10 ± 0.59 5.15 ± 0.69 5.21 ± 0.65 5.24 ± 0.95 <0.01
HOMA-IR 0.92(0.65–1.27) 0.97(0.69–1.32) 1.18(0.84–1.56) 1.25(0.88–1.80) <0.01
Total cholerterol (mmol/L) 4.89 ± 0.96 5.00 ± 1.05 4.96 ± 1.03 4.98 ± 0.98 0.42
LDL-cholesterol (mmol/L) 2.75 ± 0.70 2.88 ± 0.72 2.84 ± 0.71 2.80 ± 0.68 0.03
HDL-cholesterol (mmol/L) 1.63 ± 0.31 1.59 ± 0.30 1.52 ± 0.30 1.46 ± 0.30 <0.01
Triglycerides (mmol/L) 1.02(0.75–1.36) 1.03(0.77–1.49) 1.11(0.84–1.56) 1.25(0.88–1.80) <0.01
Creatinine (umol/L) 68.83 ± 9.63 69.50 ± 9.82 69.25 ± 10.68 67.25 ± 14.73 0.03
eGFR (ml/min/1.732) 89.73 ± 15.36 88.17 ± 15.52 89.14 ± 16.64 92.181 ± 19.12 <0.05
ALT (U/L) 14(11–19) 14(11–19) 15(12–21) 16(13–22) <0.01
AST (U/L) 21(18–25) 21(18–26) 21(18–26) 21(19–25) 0.17
NAFLD,% 3.02 % 5.39 % 8.52 % 12.56 % <0.05
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lobular inflammation [20]. Cigarette smoking is known
to cause oxidative stress and oxidative stress is a known
mechanism of injury in NAFLD [21–23]. A recent re-
search reported that cigarette smoke exposure was asso-
ciated with increased CYP2E1, which is linked to the
mechanism of oxidative injury [24].
One interesting finding from our study was that NC, a
proxy of upper-body sc fat, was a novel indicator for
identifying NAFLD in normal weight males but not in
females. NC is significantly associated with BMI, WC,
HC, systolic blood pressure, diastolic blood pressure, in-
sulin, HOMA-IR, triglycerides and ALT. NC is an
alternative measurement for upper-body subcutaneous
fat and is also a good indicator of ectopic fat distribu-
tion. Anatomically, upper-body subcutaneous fat is a
unique fat depot located in a separate compartment
compared with VAT. It has been demonstrated that
upper-body sc fat is responsible for a much larger pro-
portion of systemic free fatty acid release and this fat
depot may play an important role in risk factor patho-
genesis [11]. The liver plays a principal role in lipid
metabolic pathways by taking up serum free fatty acid
(FFA), and manufacturing, storing, and transporting lipid
metabolites [25]. The accumulation of lipids in hepato-
cytes is the hallmark feature of the pathogenesis of
NAFLD.
The differential predicting effect of NC by sex was
controversy to previously literature. Previous analyses in
the Framingham Heart Study have shown that fat depots
are more strongly associated with an adverse risk factor
profile in women compared with men [11]. One of the
possible explanations for the different results in our
study is the large proportion of smokers in males which
may result in a greater free fatty acid delivery to the
liver.
WC is often used as a surrogate marker of central
obesity as well as markers of NAFLD. Despite the estab-
lished use of the WC in the evaluation of health risk, it
has a number of limitations [26]. First, different anatom-
ical landmarks have been used to determine the exact lo-
cation for measuring WC in different clinical studies
[26]. The specific site used to measure the WC influ-
ences the absolute WC value that is obtained [26]. Sec-
ond, it is subject to variations during the day and under
health conditions affecting either the structure of the ab-
dominal wall (e.g. severe obesity, lipoabdominoplasty,
great weight loss) or abdominal organs and cavity [26].
Third, it may not be practical for large population stud-
ies, especially in cold weather and heavy clothing [26].
Measuring the NC is easier than measuring the WC,
which presents a large variability in its procedure [26].
Table 4 Correlation between neck circumference and other
parameters by sex
Variable Men Women
r p r p
Weight (kg) 0.45 <0.01 0.36 <0.01
Waist circumference (cm) 0.40 <0.01 0.40 <0.01
Hip circumference (cm) 0.37 <0.01 0.33 <0.01
Waist to hip ratio 0.05 0.18 0.22 <0.01
BMI (kg/m2) 0.41 <0.01 0.30 <0.01
SBP (mmHg) 0.18 <0.01 0.08 <0.01
DBP (mmHg) 0.09 <0.01 0.06 <0.01
FBG (mmol/L) 0.06 0.09 0.10 <0.01
Fasting insulin (pmol/L) 0.11 <0.01 0.09 <0.01
HbA1c (%) 0.11 <0.01 0.06 <0.01
HOMA-IR 0.12 <0.01 0.17 <0.01
Total cholerterol (mmol/L) 0.10 <0.01 0.02 0.51
LDL-cholesterol (mmol/L) 0.16 <0.01 0.01 0.57
HDL-cholesterol (mmol/L) −0.13 <0.01 −0.18 <0.01
Triglycerides (mmol/L) 0.14 <0.01 0.14 <0.01
Creatinine (umol/L) 0.11 <0.01 0.05 0.05
eGFR (ml/min/1.732) −0.13 <0.01 0.07 <0.01
ALT (U/L) 0.07 0.05 0.07 <0.01
All correlation coefficients were calculated after adjustment for age
Table 5 Adjusted ORs and 95 % CIs for NAFLD according to NC quartiles
ORs (95 % CI) P value for trend
NAFLD Q11 Q2 Q3 Q4
Model 1 1 1.76(0.97–3.23) 3.10(1.86–5.20) 3.98(2.21–7.16) <0.01
Model 2 1 1.81(0.99–3.31) 3.04(1.81–5.12) 3.88(2.15–7.01) <0.01
Model 3 1 1.58(0.85–2.92) 2.22(1.29–3.81) 2.36(1.27–4.40) <0.01
Model 4 1 1.51(0.81–2.82) 2.22(1.29–3.63) 2.21(1.17–4.15) <0.05
Model 5 1 1.47(0.79–2.75) 2.07(1.19–3.60) 2.18(1.16–4.13) <0.05
Model 1 adjusted for age
Model 2 further adjusted for smoking
Model 3 further adjusted for BMI
Model 4 further adjusted for TG and HOMA-IR
Model 5 further adjusted for eGFR and ALT
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Therefore, NC may have many advantages over WC in
screening NAFLD.
Obesity is a major risk factor for the development of
NAFLD and even a small elevation in body weight will
increase the risk of fatty liver formation [27, 28]. Mean-
while, previous literatures had showed that NC was an
independent predictor for fatty liver disease in the gen-
eral population. Our strong evidence indicating the cor-
relation of NC and NAFLD even in normal weighted
people may validate their results and provide valuable
clues for further studies. We also indicated that smoke
status and lipid deposition together may play important
roles in the early stage of the development of NAFLD in
male.
Despite the above findings of our project regarding the
predicting role of NC in NAFLD, we had some limita-
tions related to the cross-sectional experimental proto-
col. Even though the underlying mechanism of these
gender-based differences could not have been clarified in
this study, the gender dimorphism in the influence of re-
gional fat on the risk of developing NAFLD may be an
important area for further investigation [6].
Conclusion
In summary, we demonstrated that NC is a useful and
convenient tool for detecting NAFLD in non-obese men
but not in women. The relationship with triglyceride
supports the hypothesis that NC may be a good indica-
tor of accumulation of lipid in the liver.
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